H19 and colorectal carcinoma: To assess the correlation of H19 expression with clinicopathologic data, according to the relative H19 expression in tumor tissues, the 83 CRC patients were classified into two groups: the relative high group (n = 48, fold change ≥ 3) and the relative low group (n = 35, fold change ≤ 3) (Figure 1B).